| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.951 | 6.955 | 6.935 | 6.948 | 7.252 | 7.579 | 7.521 | 7.563 | 12.025 | 14.427 |
| Total Income - EUR | 7.018 | 6.985 | 6.935 | 6.948 | 7.252 | 7.579 | 7.521 | 7.563 | 12.025 | 14.427 |
| Total Expenses - EUR | 2.373 | 2.430 | 1.874 | 2.219 | 2.224 | 2.076 | 2.598 | 1.992 | 10.529 | 10.940 |
| Gross Profit/Loss - EUR | 4.645 | 4.555 | 5.061 | 4.729 | 5.027 | 5.502 | 4.923 | 5.571 | 1.497 | 3.487 |
| Net Profit/Loss - EUR | 4.434 | 4.345 | 4.853 | 4.520 | 4.808 | 5.292 | 4.701 | 5.386 | 1.395 | 3.350 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Anca Intermed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 7.950 | 4.451 | 4.958 | 4.852 | 4.915 | 5.391 | 5.053 | 5.520 | 7.545 | 8.993 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 1.893 | 1.861 | 1.827 | 1.791 | 2.239 | 1.848 | 1.724 | 1.718 | 2.152 |
| Cash | 7.950 | 2.558 | 3.098 | 3.026 | 3.124 | 3.151 | 3.205 | 3.796 | 5.827 | 6.841 |
| Shareholders Funds | 4.488 | 4.399 | 4.906 | 4.572 | 4.859 | 5.342 | 4.750 | 5.435 | 6.813 | 8.114 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.462 | 53 | 53 | 280 | 57 | 49 | 303 | 85 | 733 | 879 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Anca Intermed S.r.l.